EP 61: The Year 2021 in Review with Dr Sukh Nijjer — Top Trials in Heart Failure and Cardiac Surgery| finerenone, sglt2 inhibitors in heart failure, recent cardiology trials

EP 61: The Year 2021 in Review with Dr Sukh Nijjer — Top Trials in Heart Failure and Cardiac Surgery

Average (ratings)

No ratings

•

Your rating

In the second part of Parallax’s review of 2021, Dr Sukh Nijjer, Interventional Cardiologist from Imperial College London, and Dr Ankur Kalra discuss key advances in the field of heart failure and cardiac surgery.

SGLT2 inhibitors are proving to be the blockbuster drug of this decade: Sukh summarises and compares the learnings from DAPA-HF, Emperor-Reduced, and Emperor-Preserved. Next, Sukh highlights the data from SOLOIST-WHF that showed sotagliflozin to have beneficial effects on CV outcomes among patients with type 2 diabetes and HF. Additionally, they discuss how findings on finerenone (FIGARO-DKD) will shape the field. Sukh talks about the semaglutide and the STEP studies, an injectable medication that further expends cardiologist knowledge beyond their speciality. Ankur and Sukh reflect on how the advancement of this field shaped their own practices.

2021 was a busy year for cardiac surgery trials: Sukh and Ankur review the most pertinent data from the AVATAR randomised study presented at AHA 2021. Sukh interprets the outcomes and asks Ankur about his clinical experiences. Finally, they review the investigator led LAAOS III study that showed patients with atrial fibrillation undergoing cardiac surgery, left atrial appendage occlusion was superior to no occlusion.

What were the top practice informing heart failure trials of 2021? What does the latest data say on current cardiac surgery practices? How will these findings inform patient care?

Questions and comments can be sent to “podcast@radciffe-group.com” and may be answered by Ankur in the next episode. Guest @SukhNijjer, hosted by @AnkurKalraMD. Produced by @RadcliffeCARDIO.

Read MoreRead Less

Episodes

Up Next

EP 62: Bullying, Harassment and Jealousy at Workplace with Dr Srihari S Naidu

EP62 • Jan 31, 2022 • 43m 38s

In this week's Parallax, Dr Ankur Kalra is joined by Dr Srihari S Naidu, Director of Cath Labs and Hypertrophic Cardiomyopathy Center at the Westchester Medical Center and President Elect of NY ACC, for an honest conversation on a challenging topic within the cardiology community.

All Episodes

EP 64: Patient Advocate, CHD Care and the Mission of Team Uncle Joe with Joe Valente

EP64 • Feb 28, 2022 • 30m 41s

Parallax host Dr Ankur Kalra invites Joe Valente, a Board-Certified Patient Advocate (BCPA) and Co-Founder of Team Uncle Joe, to talk about his mission and practical considerations involving CHD care both from a patient and a healthcare provider perspective. In this informative and practical episode, Joe shares details about the process of getting certified as a BCPA and about the work that goes into setting up a non-profit organization. We learn more about how he and his team can support patients with CHD and what he considers to be the pillar of good patient-doctor communication.

EP 63: Innovation, Research, and the Concept of Hemorrhagic MI with Dr Rohan Dharmakumar

EP63 • Feb 14, 2022 • 41m 7s

In this week’s Parallax podcast, Dr Ankur Kalra welcomes Dr Rohan Dharmakumar, Executive Director of the Krannert Cardiovascular Research Center at IU School of Medicine, to talk about his research on hemorrhagic myocardial infarction (MI).

EP 62: Bullying, Harassment and Jealousy at Workplace with Dr Srihari S Naidu

EP62 • Jan 31, 2022 • 43m 38s

EP 61: The Year 2021 in Review with Dr Sukh Nijjer — Top Trials in Heart Failure and Cardiac Surgery

EP61 • Jan 17, 2022 • 53m 30s

EP 60: The Year 2021 in Review with Dr Sukh Nijjer – Part 1

EP60 • Dec 27, 2021 • 59m 18s

In the last Parallax episode of the year, Dr Ankur Kalra welcomed back Dr Sukh Nijjer, Interventional Cardiologist from Imperial College London, to review the most impactful events and advances in cardiology from 2021.

Parallax AHA Edition: 3 Trials that will change your practice with Dr Amit Khera

EP59 • Dec 06, 2021 • 44m 29s

In this AHA 2021 episode of Parallax, Dr Ankur Kalra’s guest is Dr Amit Khera, Professor and Director of Preventive Cardiology at UT Southwestern Medical Center, Dallas and Vice Chair of the Scientific Sessions. For this week’s show, Dr Khera selected three thought-provoking late-breaking trials that will inform or change clinical practice.

Parallax TCT Edition: 3 Trials that will Change Your Practice with Prof Mamas Mamas

EP58 • Nov 15, 2021 • 47m 52s

In this TCT 2021 episode of Parallax, Dr Ankur Kalra’s guest is Prof Mamas Mamas, Consultant Interventional Cardiologist at University Hospitals of North Midlands NHS Trust (UHNM), Professor of Cardiology at Keele University and Senior Clinical Editor of TCTmd.

EP 57: Academic Success, Decision-making & Pragmatic Approach with Dr. Ambarish Pandey

EP57 • Nov 03, 2021 • 45m 52s

In celebration of Diwali, Dr. Ankur Kalra sat down with Dr. Ambarish Pandey, Assistant Professor at The University of Texas Southwestern Medical School, to talk about his career path and the questions that shaped his decision-making over the years.

Parallax HFSA Edition: Diversity, Equity, Inclusion & Belonging with Dr Nancy M. Albert

EP56 • Oct 11, 2021 • 44m 26s

This week’s Parallax in collaboration with the Heart Failure Society of America (HFSA) explores the many ways organisations can embrace the needs of a diverse community and create a culture that can react to the realities of patientcare.

EP 55: 5 Interventional trials that will change your practice: Review of ESC 21 with Dr Mirvat Alasnag

EP55 • Sep 28, 2021 • 53m 38s

In the second ESC 2021 episode of Parallax, Dr Ankur Kalra’s guest is Dr. Mirvat Alasnag, interventional Cardiologist and Director of Catheterization Laboratory at the King Fahad Armed Forces Hospital (KFAFH) in Saudi Arabia. Dr Alasnag was a programme committee member at this year’s ESC and regional PI of one of the late-breaking trials presented.

... 2 3 4 5 6 7 8 9 10 ...

EP 44: Refugee, Dishwasher, Cardiologist, Humanitarian: The Journey of Dr Heval Kelli

EP44 • Mar 22, 2021 • 46m 8s

How can we use our power and privilege to serve? How did his experiences shape Dr Kelli to become an ambassador for his community? What is his message to our listeners?
Just after 9/11, Heval, the 18-year-old Syrian Kurdish refugee found a job as a dishwasher. At this point, he was the sole provider of his family. The pressure that comes from being poor did not leave him for many years. Today, he is firm believer in giving back to underserved communities by spreading awareness within the medical community. As he says, well-meaning people of privilege are sometimes afraid to act. What we need is more people to bridge the gap and find ways to help each other.

EP 43: Dr Nishtha Sodhi on Mentorship, Innovation and Inclusivity

EP43 • Mar 08, 2021 • 47m 20s

Dr Sodhi remembers the first time she stepped into a Cath lab and found her passion. Years later she was preparing to do a complex TAVR procedure with her colleagues when suddenly they all recognised the significance of four women coming together in the lab. The photo of the four of them was shared widely on social media. For Dr Sodhi it became a symbol of what great mentorship can achieve, and for many others it is a beacon of hope.
What drives Dr Nishtha Sodhi? What were the formative moments of Dr Sodhi’s career? What are the new frontiers of cardiology?

EP 42: Dr Hafiza Khan on Trust, Patient Outreach and Instagram

EP42 • Feb 22, 2021 • 45m 37s

In one of her many posts on Instagram, we can see Dr Hafiza Khan holding a table summarising her reactogenicity after her second COVID shot. In the frame next to her is her son listing his own reactions. In this episode, Ankur asks Hafiza to talk about Instagram and reaching millennial and gen Z audiences, as well as the importance of developing and maintaining trust between different communities at a time of information overload.

EP 41: Mallory Abbott on Ebstein’s Anomaly, Self-Care & Gratitude

EP 41: Mallory Abbott on Ebstein’s Anomaly, Self-Care & the Power of Gratitude

EP41 • Feb 09, 2021 • 42m 26s

Mallory was not prepared when she underwent her first heart surgery in seventh grade: She was hoping to regain her stamina, instead she experienced what she describes as a loss of self. Mallory was born with a rare heart disease called a Ebstein’s anomaly.

40: Mentorship, Reflection & the Journey of Mandeep R Mehra

EP40 • Jan 25, 2021 • 46m 33s

How does Dr Mehra think about building opportunities? What were his formative experiences? How does he think about the role of mentorship in medicine? What is Dr Mehra’s message to our listeners?Dr Mehra does not frame his experiences as failures or successes; he looks at all events with one question in mind: What can I learn from this?

In this week’s episode Ankur’s guest is Dr Mandeep R Mehra, Medical Director of Brigham Heart and Vascular Center and Professor of Medicine at Harvard Medical School.

... 13 14 15 16 17 18 ...